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at www.jvascsurg.org.DISCUSSIONDr John F. Eidt (Little Rock, Ark). Hemodynamic instability
following carotid endarterectomy has been a topic of considerable
debate for as long as I can remember. We have argued the merits
of local vs regional anesthesia, eversion vs conventional endarterec-
tomy, preservation vs ablation of the carotid sinus nerves, and strict
blood pressure control vs watchful waiting. Vascular surgeons tend
to have very strong opinions regarding the appropriate manage-
ment of periprocedural blood pressure, often based on anecdote
and personal tragedy. Using the VSGNE database, the authors
have attempted to shed some light on this question.
From a population of nearly 7000 carotid endarterectomies
(80% of which were for asymptomatic disease), more than 25%
of patients were treated with vasoactive medications in the postop-
erative period for either hyper- or hypotension. In brief, it appears
that patients who are treated pharmacologically for blood pressure
instability in the postoperative period have higher rates of adverse
cardiovascular outcomes including stoke, death, and MI, and in
the case of hypotension, increased 1-year mortality. Eversion
endarterectomy and the use of locoregional anesthesia were associ-
ated with reduced risk of postoperative hypotension.
The VSGNE has provided us with the answer to a number of
important clinical questions. Unfortunately, I fear that the present
study is constrained by the limitations of the database. On the
postoperative data entry form, there are two check boxes: one
for treatment of hypertension, and the other for hypotension.
Unfortunately, the database does not provide detailed information
regarding the severity of hemodynamic instability including the
absolute blood pressure or its variability. Nor does it provide
detailed information regarding the speciﬁc pharmacological inter-
ventions. In fact, due to the absence of hemodynamic data, it is
unknown whether patients in the control group had similar hemo-
dynamic instability or were simply not treated.
I have three questions:
1. Can you determine if the likelihood of pharmacological treat-
ment of perioperative blood pressure instability is surgeon
speciﬁc? Are some surgeons simply more likely to treat blood
pressure problems than others?
2. Can you differentiate patients who were treated because of
symptoms such as altered mental status, chest pain, or arrhyth-
mias vs those who were completely asymptomatic? Can you
determine from your data the incidence of complications that
might be attributed to the administration of vasoactive agents?
Is it the lowblood pressure that is associatedwith adverse cardio-
vascular events or the treatment of the low blood pressure?
3. What should we do with these data? Can these data be used to
better select anesthetic or surgical technique or perioperative
management strategy?I have one ﬁnal editorial comment: The data available in the
VSGNE are insufﬁciently granular to deﬁnitively answer this
question. Clearly, future studies with additional data will be
required. Unfortunately, I fear that the burden of more data
entry will fall on the surgeon e either in time or in dollars for
additional personnel. We have all become overwhelmed with
completing computerized checkboxes with each new request
for data preceded by the apology that “it only takes a couple
of minutes.” At some point, we need to see a convergence of
data sources across hospital information technologies that will
ﬁnally improve our ability to care for patients rather than
turning us increasingly into data entry technicians. Just as the
black box passively records events on the ﬂight deck, I believe
that we should push for better IT support so that data are
downloaded directly into relevant databases without disrupting
the pilot and crew. Thank you for the privilege of discussing
this paper.
Dr Tze-Woei Tan. Thank you for the comment. For question
one, whether there was any surgeon or center bias, when we look
at utilization of IV MED in high-volume centers and the surgeons
in VSGNE, there was no obvious outlier that use does or does not
use this medication.
For question two, whether the medication was started due to
onset of new symptoms or whether they are started just to treat
a number, due to the limitation of data set, we do not have that
answer.
For question number three, whether the use of this medica-
tion causes complications or rather for example when the patient
had new neurological symptoms after the surgery and medical
was started to treat those new ﬁndings, again, we were not able
to address that using this dataset.
Lastly, what can we do with this ﬁnding? I think when we
decided to go ahead and analyze these data, and we had the similar
issues of not being able to address the exact criteria, the trigger, the
type of medication use, the length of infusion using this dataset, we
proceeded because we can analyze large numbers of patients and
mixed populations of patients treated in tertiary and community
centers, who developed these hemodynamic changes after CEA.
We think the data might reﬂect a real practice pattern. What do
we do with the data? We try to identify these at-risk patients after
CEA. From our data, we know that patients who had signiﬁcant
hypertension are different than those who had signiﬁcant hypoten-
sion based on outcome and characteristics. Although we could not
reliably identify patients judging on AUC value on our predictive
model, we should try to optimize perioperative management of
these at-risk patients who develop signiﬁcant blood pressure
changes after CEA.
